Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT LLC | 02-14-2024 | 12-31-2023 | 67 | 335,961,131 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| Alkermes Plc | EQUITIES | Liquidated | $0 | 0 | 0.00 | 0.00 | 1,455 | 3.64 | 12-31-2023 |
| Trevi Therapeutics Inc | EQUITIES | 202 | $1,157,603 | 863,883 | 0.00 | 0.00 | -63,532 | -6.85 | 12-31-2023 |
| Schrodinger Inc | EQUITIES | 203 | $1,113,989 | 31,117 | 0.00 | 0.00 | 806 | 2.66 | 12-31-2023 |
| Viridian Therapeutics Inc | EQUITIES | 204 | $1,098,540 | 50,438 | 0.00 | 0.00 | 3,000 | 6.32 | 12-31-2023 |
